Following the goals of Saudi Arabia’s health sector transformation program, Alpha Pharma entered into a newstrategic partnership with ACINO – a leading provider of high-quality pharmaceutical products and services to cover the licensing, manufacturing, and supply of select ACINO products across the kingdom.  

“Acino is committed to advancing the development of healthcare across Saudi Arabia by accelerating access to high-quality medicines that patients and the government can trust and value,” said Fahad Al Otaibi, Country Manager for Saudi Arabia, Acino. “As part of our expansion in the Kingdom, our partnership with Alpha will allow us to further enhance patient services and promote higher standards. We shall work diligently and tirelessly towards better outcomes in care that lay the foundation for a more prosperous society.”

“This agreement between Alpha Pharma and Acino is a key step in the furtherance of the goals that underpin the Health Sector Transformation Programme, the National Transformation Programme, and Vision 2030,” said Dr. Murad Al Saggaf, GM, Alpha Pharma. “Our collaboration will feed directly into the country’s ongoing enhancement of key services. By enhancing access to affordable high-quality medicines, we strengthen a vital part of the healthcare industry and align with national initiatives aimed at building 

Read more: